908 related articles for article (PubMed ID: 11869841)
1. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
Grimm W; Hoffmann J Jü; Müller HH; Maisch B
J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
[TBL] [Abstract][Full Text] [Related]
2. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
[TBL] [Abstract][Full Text] [Related]
3. Value of heart rate variability to predict ventricular arrhythmias in recipients of prophylactic defibrillators with idiopathic dilated cardiomyopathy.
Grimm W; Herzum I; Müller HH; Christ M
Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):411-5. PubMed ID: 12687856
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
5. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
6. Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction.
Lessmeier TJ; Lehmann MH; Steinman RT; Fromm BS; Akhtar M; Calkins H; DiMarco JP; Epstein AE; Estes NA; Fogoros RN
Am J Cardiol; 1993 Oct; 72(12):911-5. PubMed ID: 8213548
[TBL] [Abstract][Full Text] [Related]
7. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
8. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
[TBL] [Abstract][Full Text] [Related]
9. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators.
Pires LA; May LM; Ravi S; Parry JT; Lal VR; Nino CL
Am J Cardiol; 2000 Mar; 85(6):725-8. PubMed ID: 12000047
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
11. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
Brembilla-Perrot B; Suty-Selton C; Beurrier D; Houriez P; Nippert M; de la Chaise AT; Louis P; Claudon O; Andronache M; Abdelaal A; Sadoul N; Juillière Y
J Am Coll Cardiol; 2004 Aug; 44(3):594-601. PubMed ID: 15358027
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography.
Grimm W; Glaveris C; Hoffmann J; Menz V; Müller HH; Hufnagel G; Maisch B
Am Heart J; 2000 Jul; 140(1):43-51. PubMed ID: 10874262
[TBL] [Abstract][Full Text] [Related]
13. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
14. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
[TBL] [Abstract][Full Text] [Related]
15. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
[TBL] [Abstract][Full Text] [Related]
16. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
[TBL] [Abstract][Full Text] [Related]
17. Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions.
Bänsch D; Brunn J; Castrucci M; Weber M; Gietzen F; Borggrefe M; Breithardt G; Block M
J Am Coll Cardiol; 1998 Mar; 31(3):608-15. PubMed ID: 9502643
[TBL] [Abstract][Full Text] [Related]
18. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
Zhu DW; Sun H; Hill R; Roberts R
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):299-302. PubMed ID: 9474693
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
[TBL] [Abstract][Full Text] [Related]
20. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
Naruse Y; Nogami A; Shinoda Y; Hanaki Y; Shirai Y; Kowase S; Kurosaki K; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
